Amanote Research
Register
Sign In
E3 Ubiquitin Ligases in Cancer and Their Pharmacological Targeting
doi 10.5772/intechopen.82883
Full Text
Open PDF
Abstract
Available in
full text
Date
June 19, 2019
Authors
Joseph Y. Ong
Jorge Z. Torres
Publisher
IntechOpen
Related search
E3 Ubiquitin Ligases in ErbB Receptor Quantity Control
Seminars in Cell and Developmental Biology
Developmental Biology
Cell Biology
RNA-binding E3 Ubiquitin Ligases: Novel Players in Nucleic Acid Regulation
Biochemical Society Transactions
Biochemistry
Emerging Roles of HECT‐type E3 Ubiquitin Ligases in Autophagy Regulation
Molecular Oncology
Cancer Research
Medicine
Oncology
Genetics
Molecular Medicine
The Importance of Ubiquitin E3 Ligases, SCF and APC/C, in Human Cancers
Medicine and Pharmacy Reports
Medicine
Herpesviruses Possess Conserved Proteins for Interaction With Nedd4 Family Ubiquitin E3 Ligases
Scientific Reports
Multidisciplinary
Targeting HECT-type E3 Ligases - Insights From Catalysis, Regulation and Inhibitors
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics
Inhibiting E3 Ligases
Science-Business eXchange
Functional Characterization of Anaphase Promoting Complex/Cyclosome (APC/C) E3 Ubiquitin Ligases in Tumorigenesis
Biochimica et Biophysica Acta - Reviews on Cancer
Cancer Research
Oncology
Genetics
E3 Ubiquitin Ligases CBL-B and C-CBL Downregulate PD-L1 in EGFR Wild-Type Non-Small Cell Lung Cancer
FEBS Letters
Genetics
Cell Biology
Molecular Biology
Biochemistry
Structural Biology
Biophysics